SMS Pharmaceuticals peers

·Pharma & HealthChart ›

Companies like SMS Pharmaceuticalslatest year

SMS PharmaceuticalsSMSPHARMA · FY26 · this company
Market cap₹4,453
P/E42.64×
Sales growth+5.6%
ROE14.3%
Ind-Swift LaboratoriesINDSWFTLAB · FY26
Open ›
Market cap₹3,291
P/E76.56×
Sales growth+25.4%
ROE3.2%
Solara Active Pharma SciencesSOLARA · FY26
Open ›
Market cap₹2,910
P/E—
Sales growth+33.1%
ROE−0.6%
Dishman Carbogen AmcisDCAL · FY26
Open ›
Market cap₹2,334
P/E23.93×
Sales growth−4.3%
ROE1.6%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SMSPHARMA₹475.45

SMS Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersINDSWFTLABSOLARADCALUNICHEMLABGUFICBIORPGLIFEHIKALGUJTHEMMcap ₹4,453 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SMSPHARMA
FY26
INDSWFTLAB
FY26
SOLARA
FY26
DCAL
FY26
Peer
Average
Valuation — at last close
P/E42.64×76.56×—◆ 23.93×50.24× -15%
P/B5.67×2.38×2.32×◆ 0.35×1.68× +237%
EV/EBITDA27.86×63.57×18.87×◆ 7.25×29.90× -7%
Market Cap₹4,453 Cr₹3,291 Cr₹2,910 Cr₹2,334 Cr₹2,845 Cr +57%
Growth
Revenue CAGR 3Y◆ 19.32%-19.01%-1.76%6.71%-4.69% +512%
Revenue CAGR 5Y◆ 9.51%—-3.27%8.93%2.83% +236%
Net Income CAGR 3Y—-4.53%——-4.53%
Revenue YoY (latest Q)5.57%25.35%◆ 33.11%-4.29%18.06% -69%
Net Income YoY (latest Q)2.04%181.32%◆ 381.78%-347.24%71.95% -97%
Profitability
EBITDA Margin◆ 19.31%7.03%13.64%19.29%13.32% +45%
Net Income Margin◆ 11.50%6.46%-0.54%3.32%3.08% +273%
Return on Common Equity◆ 14.32%3.24%-0.63%1.56%1.39% +930%
Return on Capital Employed◆ 14.30%1.10%6.39%2.57%3.35% +326%
Return on Assets◆ 8.11%2.66%-0.32%0.89%1.08% +653%
Credit & Quality
Total Debt/Equity0.46×◆ 0.01×0.53×0.42×0.32× +44%
Interest Coverage5.69×◆ 10.31×0.92×1.30×4.18× +36%
Scale — latest FY
Revenue / Total Income₹887 Cr₹641 Cr₹1,369 Cr₹2,932 Cr₹1,647 Cr -46%
Net Income₹102 Cr₹41.4 Cr−₹7.4 Cr₹97.5 Cr₹43.8 Cr +133%
Total Assets₹1,362 Cr₹1,673 Cr₹2,333 Cr₹11,923 Cr₹5,310 Cr -74%
EPS₹11.15₹4.95₹-1.68₹6.22₹3.16 +252%
Book Value per Share₹83.91₹159.38₹281.48₹425.82₹288.89 -71%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.